Free · No account

Create your own personal news briefing

A daily PDF of the news that moves your tickers — summaries and market impact, delivered an hour before the open.

Zacks Investment Research

27 Jul 2026, 16:43 UTC · 2h ago

PAHC vs. SYK: Which Stock Is the Better Value Option?

NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims

3 claims · each scored for market impact

What matters in this story

1
Phibro Animal Health (PAHC) currently holds a Zacks Rank of #2 (Buy) and a Value grade of 'A'. — A high analyst rank combined with a top value grade suggests a bullish setup for the individual stock.
+0.30
2
PAHC exhibits lower valuation multiples than SYK, with a forward P/E of 10.24 and a PEG ratio of 0.48. — Low P/E and PEG ratios indicate the stock may be undervalued relative to its growth potential.
+0.20
3
Stryker (SYK) currently holds a Zacks Rank of #3 (Hold) and a Value grade of 'C'. — A 'Hold' rank and mediocre value grade suggest limited immediate upside compared to higher-ranked peers.
-0.10